Overexpression of the Wiskott-Aldrich syndrome protein N-terminal domain in transgenic mice inhibits T cell proliferative responses via TCR signaling without affecting cytoskeletal rearrangements.

作者: Mitsuru Sato , Noriko M. Tsuji , Hideo Gotoh , Keizo Yamashita , Koichi Hashimoto

DOI: 10.4049/JIMMUNOL.167.8.4701

关键词: T-cell receptorPleckstrin homology domainCytoskeletonMolecular biologyT cellGenetically modified mouseBiologyWiskott–Aldrich syndrome proteinActinSignal transduction

摘要: Wiskott-Aldrich syndrome (WAS) is an X-linked recessive disorder characterized by thrombocytopenia with small platelets, severe eczema, and recurrent infections due to defects in the immune system. The disease arises from mutations gene encoding WAS protein (WASP), which plays a role as adaptor molecule signal transduction accompanied cytoskeletal rearrangement T cells. To investigate functional domain of WASP, we developed transgenic mice overexpressing WASP N-terminal region (exon 1–5) including Ena/VASP homology 1 (pleckstrin homology/WASP 1) domain, majority patients have been observed. develop grow normally under specific pathogen-free environment, showed normal lymphocyte development. However, proliferative responses cytokine production induced TCR stimulation were strongly inhibited mice, whereas Ag receptor capping actin polymerization normal. These findings suggest that overexpressed inhibits signaling without coupling rearrangement. shown here could be valuable tools for further understanding WASP-mediated processes.

参考文章(44)
HD Ochs, SJ Slichter, LA Harker, WE Von Behrens, RA Clark, RJ Wedgwood, The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets Blood. ,vol. 55, pp. 243- 252 ,(1980) , 10.1182/BLOOD.V55.2.243.243
E Remold-O'Donnell, FS Rosen, DM Kenney, Defects in Wiskott-Aldrich syndrome blood cells Blood. ,vol. 87, pp. 2621- 2631 ,(1996) , 10.1182/BLOOD.V87.7.2621.BLOODJOURNAL8772621
P. M. Brickell, S. Banin, C. Kinnon, R. C. Lovering, I. Gout, G. O. C. Cory, R. J. Levinsky, L. Maccarthy-Morrogh, Evidence that the Wiskott-Aldrich syndrome protein may be involved in lymphoid cell signaling pathways. Journal of Immunology. ,vol. 157, pp. 3791- 3795 ,(1996)
Violaine Moreau, Friedrich Frischknecht, Inge Reckmann, Renaud Vincentelli, Gwénaël Rabut, Donn Stewart, Michael Way, A complex of N-WASP and WIP integrates signalling cascades that lead to actin polymerization. Nature Cell Biology. ,vol. 2, pp. 441- 448 ,(2000) , 10.1038/35017080
Doris N. Savoy, Daniel D. Billadeau, Paul J. Leibson, Cutting Edge: WIP, a Binding Partner for Wiskott-Aldrich Syndrome Protein, Cooperates with Vav in the Regulation of T Cell Activation The Journal of Immunology. ,vol. 164, pp. 2866- 2870 ,(2000) , 10.4049/JIMMUNOL.164.6.2866
N Yonezawa, E Nishida, H Sakai, pH Control of Actin Polymerization by Cofilin Journal of Biological Chemistry. ,vol. 260, pp. 14410- 14412 ,(1985) , 10.1016/S0021-9258(17)38580-0
E Remold-O'Donnell, C Terhorst, J Sancho, F S Rosen, I J Molina, T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. Journal of Immunology. ,vol. 151, pp. 4383- 4390 ,(1993)
D Kenney, L Cairns, E Remold-O'Donnell, J Peterson, FS Rosen, R Parkman, Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome Blood. ,vol. 68, pp. 1329- 1332 ,(1986) , 10.1182/BLOOD.V68.6.1329.1329
Lan Tian, Donn M. Stewart, David L. Nelson, Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein. Journal of Immunology. ,vol. 162, pp. 5019- 5024 ,(1999)